المؤلفون: Satheesha S; Leeds Institute of Molecular Medicine, St, James's University Hospital, Leeds University, UK., Cookson VJ, Coleman LJ, Ingram N, Madhok B, Hanby AM, Suleman CA, Sabine VS, Macaskill EJ, Bartlett JM, Dixon JM, McElwaine JN, Hughes TA

المصدر: Molecular cancer [Mol Cancer] 2011 Feb 14; Vol. 10, pp. 19. Date of Electronic Publication: 2011 Feb 14.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms/*metabolism , Eukaryotic Initiation Factor-4E/*metabolism , TOR Serine-Threonine Kinases/*antagonists & inhibitors, 5' Untranslated Regions/genetics ; Adaptor Proteins, Signal Transducing/metabolism ; Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Breast Neoplasms/surgery ; Cell Cycle Proteins ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Drug Screening Assays, Antitumor ; Eukaryotic Initiation Factor-4E/genetics ; Everolimus ; Female ; Gene Expression Regulation, Neoplastic/drug effects ; Genes, Reporter ; Humans ; Phosphoproteins/metabolism ; Phosphorylation/drug effects ; Preoperative Care ; Protein Biosynthesis/drug effects ; Sirolimus/analogs & derivatives ; Sirolimus/pharmacology ; TOR Serine-Threonine Kinases/metabolism ; Tissue Culture Techniques